Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 53.00
-0.10 (-0.19%)
Sep 4, 2026, 5:29 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 14.3 billion as of September 4, 2026. Its market cap has decreased by -6.59% in one year.
Market Cap
14.30B
Enterprise Value
15.58B
Revenue
9.43B
Ranking
n/a
PE Ratio
20.04
Stock Price
53.00
ChartMarket Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 14.30B, an increase of 2,066.23%. That is a compound annual growth rate of 10.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 14.30B | -14.08% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 66.73B |
| Sectra AB | 55.18B |
| Elekta AB | 20.93B |
| Vitrolife AB | 12.80B |
| MedCap AB | 8.31B |
| Xvivo Perfusion AB | 8.28B |
| CellaVision AB | 3.88B |
| BICO Group AB | 1.58B |